• 1. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 2. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 3. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

Introduction to 6-Methylnicotinoyl hydrazide (CAS No. 197079-25-7) and Its Emerging Applications in Chemical Biology

6-Methylnicotinoyl hydrazide, identified by the chemical abstracts service number 197079-25-7, is a specialized organic compound that has garnered significant attention in the field of chemical biology due to its unique structural properties and potential biological activities. This hydrazide derivative, featuring a nicotinoyl moiety with a methyl substituent, presents an intriguing scaffold for further chemical modifications and functional exploration. The compound’s molecular structure, characterized by a hydrazide group (-NH?) attached to a nicotinoyl backbone, makes it a versatile intermediate in synthetic chemistry and a promising candidate for drug discovery initiatives.

The nicotinoyl moiety in 6-Methylnicotinoyl hydrazide is derived from nicotinic acid (niacin), a well-known B-complex vitamin with established roles in metabolic processes. Hydrazides, on the other hand, are well-documented pharmacophores that exhibit diverse biological interactions, including enzyme inhibition and receptor binding. The combination of these two functional groups in 6-Methylnicotinoyl hydrazide suggests potential applications in modulating biological pathways associated with inflammation, oxidative stress, and neurodegeneration. Recent studies have highlighted the hydrazide group’s ability to form stable adducts with reactive carbonyl species, making it a valuable tool for investigating redox signaling mechanisms.

In the realm of medicinal chemistry, 6-Methylnicotinoyl hydrazide (CAS No. 197079-25-7) has been explored as a precursor for designing novel bioactive molecules. The methyl substituent on the nicotinoyl ring may influence the compound’s pharmacokinetic properties, such as solubility and metabolic stability, which are critical factors in drug development. Researchers have leveraged this compound to develop derivatives with enhanced binding affinity to target proteins or improved pharmacological profiles. For instance, modifications of the hydrazide group have been investigated to enhance its bioavailability while maintaining or improving its therapeutic efficacy.

Recent advancements in computational chemistry have enabled the rapid screening of virtual libraries containing 6-Methylnicotinoyl hydrazide derivatives to identify candidates with high potential for further optimization. Machine learning models have been trained on large datasets of bioactive compounds to predict the biological activity of novel scaffolds, including those derived from 6-Methylnicotinoyl hydrazide. These computational approaches have accelerated the discovery process by prioritizing promising compounds based on their predicted binding interactions with biological targets such as kinases, proteases, and transcription factors.

The chemical biology applications of 6-Methylnicotinoyl hydrazide extend beyond drug discovery to include its use as a tool for probing cellular mechanisms. The compound’s ability to react with electrophilic species has been exploited in studying oxidative stress-related diseases, such as Alzheimer’s and Parkinson’s. By covalently modifying target proteins or lipids, 6-Methylnicotinoyl hydrazide has provided insights into the molecular pathways underlying these conditions. Additionally, its derivatives have been employed in developing probes for imaging intracellular signaling events, further demonstrating its utility in biochemical research.

The synthesis of 6-Methylnicotinoyl hydrazide (CAS No. 197079-25-7) involves multi-step organic transformations that require precise control over reaction conditions to ensure high yield and purity. Advances in synthetic methodologies have enabled more efficient production processes, making it feasible to scale up synthesis for research and industrial applications. Techniques such as flow chemistry and microwave-assisted synthesis have been particularly useful in optimizing reaction conditions while minimizing waste generation—a critical consideration in sustainable chemistry practices.

The pharmaceutical industry has shown interest in 6-Methylnicotinoyl hydrazide due to its potential as an intermediate for producing lead compounds with therapeutic value. Collaborative efforts between academic researchers and pharmaceutical companies have led to several patents describing novel derivatives of this compound with improved pharmacological properties. These derivatives are being evaluated in preclinical studies to assess their safety and efficacy against various disease targets. The growing body of evidence supporting the biological activity of 6-Methylnicotinoyl hydrazide underscores its significance as a building block in modern drug discovery.

In conclusion, 6-Methylnicotinoyl hydrazide (CAS No. 197079-25-7) represents a fascinating compound with broad applications in chemical biology and pharmaceutical research. Its unique structural features make it a valuable intermediate for designing novel bioactive molecules, while its reactivity allows for detailed investigation of cellular mechanisms relevant to human health and disease. As synthetic methods continue to evolve and computational tools become more sophisticated, the potential applications of this compound are expected to expand further, driving innovation across multiple disciplines.

• 6964-72-3(Pyridinium,3-(hydrazinylcarbonyl)-1-methyl-, iodide (1:1))
• 553-53-7(Nicotinohydrazide)
• 15420-53-8(3,5-Pyridinedicarboxylicacid, 3,5-dihydrazide)
• 182159-58-6(3-Pyridinecarboxamide,6-(aminomethyl)-)
• 3758-59-6(2-Methylisonicotinohydrazide)
• 15420-54-9(3,5-Pyridinedicarboxylicacid, 2,6-dimethyl-, 3,5-dihydrazide)
• 500302-91-0(2-Methyl-1H-pyrrole-3-carbohydrazide)
• 6960-22-1(6-Methylnicotinamide)
• 197079-01-9(2-Methylnicotinohydrazide)
• 500302-92-1( )